(Q63352440)
Statements
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort (English)
M Cossburn
A A Pace
J Jones
R Ali
G Ingram
K Baker
C Hirst
J Zajicek
M Boggild
T Pickersgill
A Coles
N P Robertson